SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma.
De-Chao FengFacai ZhangLing LiuQiao XiongHang XuWuran WeiZhenghua LiuLu YangPublished in: International journal of general medicine (2021)
SKA3 might contribute to poor prognosis of KIRP through cell cycle, DNA damage, hormone androgen receptor, hormone estrogen receptor, PI3K/Akt, and RAS/MAPK. SKA3 potentially serves as a prognostic biomarker and target for KIRP.